May 23, 2025

Peer Fischer elected Fellow of AIMBE

Peer Fischer elected Fellow of AIMBE

Peer Fischer, research group leader at the Max Planck Institute for Medical Research in Heidelberg and Professor at the Institute for Molecular Systems Engineering and Advanced Materials at Heidelberg University, has been elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).

  • Election to the AIMBE College of Fellows is one of the highest professional honors for medical and biotechnology engineers.
  • Peer Fischer was honored “for pioneering contributions in nanorobotics, the development of new ultrasound technologies, and for his leadership and engagement in translational science.”
Peer Fischer with the President of AIMBE Lola Eniola-Adefeso (right) and Yongjie Jessica Zhang, Chair of the Fellows 2024 (left).
© AIMBE

“The appointment is a great honor,” says Peer Fischer. ”I would like to thank my colleagues for their recognition and am particularly pleased that the interface between science and technology transfer, a balancing act between the disciplines in our research, has been honored in this way. This also shows that we are on the right track with our institute’s First in Translation plans for our new location in Heilbronn.”

The First in Translation initiative of the Max Planck Institute for Medical Research (MPIMR) prepares fundamental research discoveries for entrepreneurial application. With support from the Dieter Schwarz Foundation, the MPIMR is currently setting up a second site on Heilbronn’s Bildungscampus, which will also provide a home for the institute’s First in Translation activities.

Honor for pioneering work

Membership, according to AIMBE, honors individuals who have made “outstanding contributions to engineering and medicine research, practice, or education” as well as to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.”

AIMBE College of Fellows Class of 2025

The induction ceremony into the “2025 Class of the AIMBEE College of Fellows” took place during the AIMBE annual event in Arlington, Virginia, USA, on March 31, 2025. Peer Fischer was inducted along with around 170 colleagues from more than 30 countries who make up the AIMBE College of Fellows Class of 2025.

Our latest News

discover more
European Biotech Act: bioRN brings Industry and Policymakers together

European Biotech Act: bioRN brings Industry and Policymakers together

How can Europe strengthen its global competitiveness in biotechnology? Heidelberg, July 7th: This question was at the heart of a high-level roundtable hosted by the bioRN Life Science Cluster with Member of the European Parliament Hildegard Bentele. Representatives from Ascendis Pharma, BD, PROGEN, Novaliq, BASF Agricultural Solutions, PEPperPRINT, Evotec and Isenbruck Bösl Hörschler joined the […]

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

NORTH CHICAGO, Ill., July 6, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on results from the pivotal Phase 3 […]

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

It should be biofunctional – that is, it should replicate the natural cellular environment as closely as possible – and it should be printable: bioink. Achieving both of these properties at the same time is an enormous challenge that conventional biomaterials often fail to meet. Together with two partner companies, researchers at the NMI have now taken an important […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp